|
⚲
|
| Keyboard |
| Humphries William D
✚
|
|
|---|---|
| CIK # | 0001674278 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001674278] | |
| 4 | [0001674278] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aclaris Therapeutics Inc | |
| Humphries William D | |
| Clearside Biomedical Inc | |
| MELA Sciences Inc /NY | |
| PhaseBio Pharmaceuticals Inc | |
| Bausch Health Companies Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2025-06-06 | Option exercise | 4,793 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Common Stock
|
2025-06-06 | Option exercise | 4,793 | ||
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2025-06-05 | Grant | 11,580 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Stock Option (Right to Buy) · derivative
|
2025-06-05 | Grant | 42,350 | $0.00 | |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2024-06-20 | Grant | 45,000 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Stock Option (Right to Buy) · derivative
|
2024-06-06 | Grant | 15,750 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2024-06-06 | Grant | 4,793 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2024-06-01 | Option exercise | 4,660 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Common Stock
|
2024-06-01 | Option exercise | 4,660 | ||
|
Clearside Biomedical Inc CLSD
Common Stock
|
2023-09-22 | Option exercise | 22,727 | $0.40 | 9,091 |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2023-09-22 | Option exercise | 22,727 | $0.00 | |
|
MELA Sciences Inc /NY SSKN
SSKN Common Stock
|
2023-07-05 | Grant | 36,408 | $1.03 | 37,500 |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2023-06-22 | Grant | 30,000 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2023-06-02 | Option exercise | 4,507 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Common Stock
|
2023-06-02 | Option exercise | 4,507 | ||
|
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
|
2023-06-01 | Grant | 4,660 | $0.00 | |
|
Aclaris Therapeutics Inc ACRS
Stock Option (Right to Buy) · derivative
|
2023-06-01 | Grant | 15,750 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2023-05-19 | Option exercise | 2,538 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Restricted Stock Units · derivative
|
2023-05-19 | Option exercise | 2,538 | $0.00 | |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2022-06-22 | Grant | 30,000 | $0.00 | |
| showing 20 of 84 most recent transactions | |||||